Overview

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-02-28

Target enrollment:

Participant gender:

Summary

One study evaluated the efficacy and safety of intravenous STC314 injection in patients with sepsis Sex and pharmacokinetic profiles of a multicenter, randomized, double-blind, placebo-controlled II Phase I dose exploration clinical trial

Phase:

PHASE2

Details

Lead Sponsor:

Grand Medical Pty Ltd.

Treatments:

STC3141